UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 417

Sortiert nach

Protein typing of circulating microvesicles allows real-time monitoring of glioblastoma therapy

Nature medicine, 2012-12, Vol.18 (12), p.1835-1840

2012

Volltextzugriff (PDF)

Profiling the effects of isocitrate dehydrogenase 1 and 2 mutations on the cellular metabolome

Proceedings of the National Academy of Sciences - PNAS, 2011-02, Vol.108 (8), p.3270-3275

2011

Volltextzugriff (PDF)

The integrated landscape of driver genomic alterations in glioblastoma

Nature genetics, 2013-10, Vol.45 (10), p.1141-1149

2013

Volltextzugriff (PDF)

Very low mutation burden is a feature of inflamed recurrent glioblastomas responsive to cancer immunotherapy

Nature communications, 2021-01, Vol.12 (1), p.352-352, Article 352

2021

Volltextzugriff (PDF)

Systemic administration of a bispecific antibody targeting EGFRvIII successfully treats intracerebral glioma

Proceedings of the National Academy of Sciences - PNAS, 2013-01, Vol.110 (1), p.270-275

2013

Volltextzugriff (PDF)

Genetically stable poliovirus vectors activate dendritic cells and prime antitumor CD8 T cell immunity

Nature communications, 2020-01, Vol.11 (1), p.524-524, Article 524

2020

Volltextzugriff (PDF)

MiR-215 Is Induced Post-transcriptionally via HIF-Drosha Complex and Mediates Glioma-Initiating Cell Adaptation to Hypoxia by Targeting KDM1B

Cancer cell, 2016-01, Vol.29 (1), p.49-60

2016

Volltextzugriff (PDF)

Synergistic antitumor effects of 9.2.27-PE38KDEL and ABT-737 in primary and metastatic brain tumors

PloS one, 2019-01, Vol.14 (1), p.e0210608

2019

Volltextzugriff (PDF)

2-hydroxyglutarate production, but not dominant negative function, is conferred by glioma-derived NADP-dependent isocitrate dehydrogenase mutations

PloS one, 2011-02, Vol.6 (2), p.e16812-e16812

2011

Volltextzugriff (PDF)

miR-33a promotes glioma-initiating cell self-renewal via PKA and NOTCH pathways

The Journal of clinical investigation, 2014-10, Vol.124 (10), p.4489-4502

2014

Volltextzugriff (PDF)

Recent Advances in the Treatment of Malignant Astrocytoma

Journal of clinical oncology, 2006-03, Vol.24 (8), p.1253-1265

2006

Volltextzugriff (PDF)

Systemic CTLA-4 Blockade Ameliorates Glioma-Induced Changes to the CD4+ T Cell Compartment without Affecting Regulatory T-Cell Function

Clinical cancer research, 2007-04, Vol.13 (7), p.2158-2167

2007

Volltextzugriff (PDF)

KMT2D maintains neoplastic cell proliferation and global histone H3 lysine 4 monomethylation

Oncotarget, 2013-11, Vol.4 (11), p.2144-2153

2013

Volltextzugriff (PDF)

Development of a high-throughput screening platform to identify new therapeutic agents for Medulloblastoma Group 3

SLAS discovery, 2024-03, Vol.29 (2), p.100147-100147, Article 100147

2024

Volltextzugriff (PDF)

The Heat Shock Response and Chaperones/Heat Shock Proteins in Brain Tumors: Surface Expression, Release, and Possible Immune Consequences

The Journal of neuroscience, 2007-10, Vol.27 (42), p.11214-11227

2007

Volltextzugriff (PDF)

Global identification of MLL2-targeted loci reveals MLL2’s role in diverse signaling pathways

Proceedings of the National Academy of Sciences - PNAS, 2012-10, Vol.109 (43), p.17603-17608

2012

Volltextzugriff (PDF)

EGFR phosphorylation of DCBLD2 recruits TRAF6 and stimulates AKT-promoted tumorigenesis

The Journal of clinical investigation, 2014-09, Vol.124 (9), p.3741-3756

2014

Volltextzugriff (PDF)

Myeloablative temozolomide enhances CD8⁺ T-cell responses to vaccine and is required for efficacy against brain tumors in mice

PloS one, 2013-03, Vol.8 (3), p.e59082

2013

Volltextzugriff (PDF)

Induction of the unfolded protein response drives enhanced metabolism and chemoresistance in glioma cells

PloS one, 2013-08, Vol.8 (8), p.e73267

2013

Volltextzugriff (PDF)

EGFRvIII-Targeted Vaccination Therapy of Malignant Glioma

Brain pathology (Zurich, Switzerland), 2009-10, Vol.19 (4), p.713-723

2009

Volltextzugriff (PDF)

The genetic landscape of anaplastic astrocytoma

Oncotarget, 2014-03, Vol.5 (6), p.1452-1457

2014

Volltextzugriff (PDF)

Repurposing Clemastine to Target Glioblastoma Cell Stemness

Cancers, 2023-09, Vol.15 (18), p.4619

2023

Volltextzugriff (PDF)

A novel low-molecular weight inhibitor of focal adhesion kinase, TAE226, inhibits glioma growth

Molecular carcinogenesis, 2007-06, Vol.46 (6), p.488-496

2007

Volltextzugriff (PDF)

Intratumor childhood vaccine-specific CD4+ T-cell recall coordinates antitumor CD8+ T cells and eosinophils

Journal for immunotherapy of cancer, 2023-04, Vol.11 (4), p.e006463

2023

Volltextzugriff (PDF)

Intracerebral infusion of an EGFR-targeted toxin in recurrent malignant brain tumors

Neuro-oncology (Charlottesville, Va.), 2008-06, Vol.10 (3), p.320-329

2008

Volltextzugriff (PDF)

1 – 25 von 417

Suche als RSS-Feed

Aktive Filter

KollektionAmerican Association for the Advancement of Science

Zeitschrift / SerieCancer Research

ThemaFemale

ThemaTumors Of The Nervous System. Phacomatoses

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(397)
Mit Volltextzugriff
(383)

Publikationsform

Artikel
(414)
Buchkapitel
(3)

Sprache

Englisch
(417)
Japanisch
(47)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Protein typing of circulating microvesicles allows real-time monitoring of glioblastoma therapy

Profiling the effects of isocitrate dehydrogenase 1 and 2 mutations on the cellular metabolome

The integrated landscape of driver genomic alterations in glioblastoma

Very low mutation burden is a feature of inflamed recurrent glioblastomas responsive to cancer immunotherapy

Systemic administration of a bispecific antibody targeting EGFRvIII successfully treats intracerebral glioma

Genetically stable poliovirus vectors activate dendritic cells and prime antitumor CD8 T cell immunity

MiR-215 Is Induced Post-transcriptionally via HIF-Drosha Complex and Mediates Glioma-Initiating Cell Adaptation to Hypoxia by Targeting KDM1B

Synergistic antitumor effects of 9.2.27-PE38KDEL and ABT-737 in primary and metastatic brain tumors

2-hydroxyglutarate production, but not dominant negative function, is conferred by glioma-derived NADP-dependent isocitrate dehydrogenase mutations

miR-33a promotes glioma-initiating cell self-renewal via PKA and NOTCH pathways

Recent Advances in the Treatment of Malignant Astrocytoma

Systemic CTLA-4 Blockade Ameliorates Glioma-Induced Changes to the CD4+ T Cell Compartment without Affecting Regulatory T-Cell Function

KMT2D maintains neoplastic cell proliferation and global histone H3 lysine 4 monomethylation

Development of a high-throughput screening platform to identify new therapeutic agents for Medulloblastoma Group 3

The Heat Shock Response and Chaperones/Heat Shock Proteins in Brain Tumors: Surface Expression, Release, and Possible Immune Consequences

Global identification of MLL2-targeted loci reveals MLL2’s role in diverse signaling pathways

EGFR phosphorylation of DCBLD2 recruits TRAF6 and stimulates AKT-promoted tumorigenesis

Myeloablative temozolomide enhances CD8⁺ T-cell responses to vaccine and is required for efficacy against brain tumors in mice

Induction of the unfolded protein response drives enhanced metabolism and chemoresistance in glioma cells

EGFRvIII-Targeted Vaccination Therapy of Malignant Glioma

The genetic landscape of anaplastic astrocytoma

Repurposing Clemastine to Target Glioblastoma Cell Stemness

A novel low-molecular weight inhibitor of focal adhesion kinase, TAE226, inhibits glioma growth

Intratumor childhood vaccine-specific CD4+ T-cell recall coordinates antitumor CD8+ T cells and eosinophils

Intracerebral infusion of an EGFR-targeted toxin in recurrent malignant brain tumors

Aktive Filter

Suchergebnisse filtern